TEVA-CANDESARTAN/HCTZ 32 MG
CANDESARTAN CILEXETIL : 32 MG HYDROCHLOROTHIAZIDE : 12.5 MG · DIN 02395568 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is TEVA-CANDESARTAN/HCTZ?
TEVA-CANDESARTAN/HCTZ 32 MG contains CANDESARTAN CILEXETIL : 32 MG HYDROCHLOROTHIAZIDE : 12.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02395568, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 19-Jun-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-CANDESARTAN/HCTZ used for?
TEVA - CANDESARTAN/HCTZ (candesartan cilexetil/hydrochlorothiazide) is indicated for the treatment of essential hypertension in patients for whom combination therapy is appropriate. TEVA - CANDESARTAN/HCTZ is not indicated for initial therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02395568 |
|---|---|
| Brand name | TEVA-CANDESARTAN/HCTZ |
| Generic / active ingredient | CANDESARTAN CILEXETIL : 32 MG HYDROCHLOROTHIAZIDE : 12.5 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 32 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09DA06 CANDERSARTAN AND DIURETICS |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 19-Jun-2013 |
How is it stored and handled?
null
How is it supplied?
bottles of 30 and 100 tablets and blister packs of 30 tablets for 16 mg / 12.5 mg; bottles of 30 tablets and blister packs of 30 tablets for 32 mg / 12.5 mg
What can be used instead?
Other Canadian products sharing ATC code C09DA06 CANDERSARTAN AND DIURETICS. 22 of 49 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATACAND PLUS | 12.5 MG | TABLET | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02244021 |
| ATACAND PLUS | 12.5 MG | TABLET | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02332922 |
| ATACAND PLUS | 25 MG | TABLET | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02332957 |
| AURO-CANDESARTAN HCT | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02421046 |
| AURO-CANDESARTAN HCT | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02421038 |
| AURO-CANDESARTAN HCT | 25 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02421054 |
| CANDESARTAN HCT | 16 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02394812 |
| CANDESARTAN-HCTZ | 16.0 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02392275 |
| CANDESARTAN/HCTZ | 16 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02394804 |
| CANDESARTAN/HCTZ | 32 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02536064 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.